Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378050%3A_____%2F20%3A00559781" target="_blank" >RIV/68378050:_____/20:00559781 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/20:10413861 RIV/00216208:11150/20:10413861
Result on the web
<a href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00431" target="_blank" >https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00431</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1021/acs.jmedchem.0c00431" target="_blank" >10.1021/acs.jmedchem.0c00431</a>
Alternative languages
Result language
angličtina
Original language name
Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies
Original language description
Chemotherapy remains one of the dominant treatments to cure cancer. However, due to the many inherent drawbacks, there is a search for new chemotherapeutic drugs. Many classes of compounds have been investigated over the years to discover new targets and synergistic mechanisms of action including multicellular targets. In this work, we designed a new chemotherapeutic drug candidate against cancer, namely, Ru(DIP)(2)(sq)](PF6) (Ru-sq) (DIP = 4,7-diphenyl-1,10-phenanthroline, sq = semiquinonate ligand). The aim was to combine the great potential expressed by Ru(II) polypyridyl complexes and the singular redox and biological properties associated with the catecholate moiety. Experimental evidence (e.g., X-ray crystallography, electron paramagnetic resonance, electrochemistry) demonstrates that the semiquinonate is the preferred oxidation state of the dioxo ligand in this complex. The biological activity of Ru-sq was then scrutinized in vitro and in vivo, and the results highlight the promising potential of this complex as a chemotherapeutic agent against cancer.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
<a href="/en/project/GA17-02080S" target="_blank" >GA17-02080S: Study of molecular mechanisms involved in suppression of transcription-associated genomic instability</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Medicinal Chemistry
ISSN
0022-2623
e-ISSN
1520-4804
Volume of the periodical
63
Issue of the periodical within the volume
10
Country of publishing house
US - UNITED STATES
Number of pages
17
Pages from-to
5568-5584
UT code for WoS article
000585210700032
EID of the result in the Scopus database
—